Wu E - Search Results

1

Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's disease.

Yu AP, Johnson S, Wang ST, Atanasov P, Tang J, Wu E, Chao J, Mulani PM. Yu AP, et al. Among authors: wu e. Pharmacoeconomics. 2009;27(7):609-21. doi: 10.2165/11312710-000000000-00000. Pharmacoeconomics. 2009. PMID: 19663531

2

Interstitial Cystitis: Cost, treatment and co-morbidities in an employed population.

Wu EQ, Birnbaum H, Mareva M, Parece A, Huang Z, Mallett D, Taitel H. Wu EQ, et al. Pharmacoeconomics. 2006;24(1):55-65. doi: 10.2165/00019053-200624010-00005. Pharmacoeconomics. 2006. PMID: 16445303

3

Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data.

Wu E, Chen L, Birnbaum H, Yang E, Cifaldi M. Wu E, et al. Curr Med Res Opin. 2007 Aug;23(8):1749-59. doi: 10.1185/030079907X210615. Curr Med Res Opin. 2007. PMID: 17588306

4

Retrospective economic and outcomes analyses using non-US databases: a review.

Shi L, Wu EQ, Hodges M, Yu A, Birnbaum H. Shi L, et al. Pharmacoeconomics. 2007;25(7):563-76. doi: 10.2165/00019053-200725070-00003. Pharmacoeconomics. 2007. PMID: 17610337 Review.

5

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A. Yu AP, et al. Among authors: wu eq. Curr Med Res Opin. 2007 Sep;23(9):2157-69. doi: 10.1185/0300799007X219544. Curr Med Res Opin. 2007. PMID: 17669232 Review.

6

Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients.

Wu EQ, Mulani P, Farrell MH, Sleep D. Wu EQ, et al. Value Health. 2007 Sep-Oct;10(5):408-14. doi: 10.1111/j.1524-4733.2007.00195.x. Value Health. 2007. PMID: 17888106 Free article.

7

The costs of Crohn's disease in the United States and other Western countries: a systematic review.

Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J. Yu AP, et al. Curr Med Res Opin. 2008 Feb;24(2):319-28. doi: 10.1185/030079908x260790. Curr Med Res Opin. 2008. PMID: 18067689 Review.

8

Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E. Wu EQ, et al. J Manag Care Pharm. 2008 Mar;14(2):164-75. doi: 10.18553/jmcp.2008.14.2.164. J Manag Care Pharm. 2008. PMID: 18331118 Free PMC article.

9

Loss of treatment response to infliximab maintenance therapy in Crohn's disease: a payor perspective.

Wu EQ, Mulani PM, Yu AP, Tang J, Pollack PF. Wu EQ, et al. Value Health. 2008 Sep-Oct;11(5):820-9. doi: 10.1111/j.1524-4733.2008.00335.x. Epub 2008 May 16. Value Health. 2008. PMID: 18489509 Free article.

10

Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population.

Wu E, Greenberg PE, Yang E, Yu A, Erder MH. Wu E, et al. Curr Med Res Opin. 2008 Sep;24(9):2587-95. doi: 10.1185/03007990802303525. Epub 2008 Jul 31. Curr Med Res Opin. 2008. PMID: 18674407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,551 results

Search Page

Filters